Arvinas ARVN
NASDAQ ARVN
$9.39 +0.08 (+0.86%)
As of: Sep 4, 2026 · 3:59 PM EDT

Arvinas (ARVN) Interest Expenses (2017 - 2021)

Arvinas (ARVN) posted quarterly Interest Expenses of $3.9 million for Q1 2026, down 66.95% year-over-year from $11.8 million in Q1 2025, and up 875.0% quarter-over-quarter from $400000.0 in Q4 2025.

Analysis

Arvinas (ARVN) Interest Expenses (2017 - 2021) Analysis & Trends

Arvinas' Interest Expenses history runs 10 years deep, the most recent figure standing at $3.9 million for Q1 2026.

  • In Q1 2026, Interest Expenses fell 66.95% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (down 66.95% YoY), while the FY2025 annual figure was $481.4 million, up 2.12% from the prior year.
  • Interest Expenses for Q1 2026 stood at $3.9 million, up from $400000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $11.8 million in Q1 2025, with the low at $400000.0 in Q4 2025.
  • The 5-year median for Interest Expenses is $2.5 million (2025), against an average of $3.1 million.
  • The sharpest annual moves came in 2022 and 2023: Interest Expenses tumbled 99.75% in 2022, then surged 640.0% in 2023.
  • Arvinas' Interest Expenses stood at $2.2 million in 2022, then plunged by 77.27% to $500000.0 in 2023, then surged by 260.0% to $1.8 million in 2024, then tumbled by 77.78% to $400000.0 in 2025, then surged by 875.0% to $3.9 million in 2026.
  • Business Quant data shows ARVN's Interest Expenses at $3.9 million in Q1 2026, $400000.0 in Q4 2025, and $2.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 23.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 93.62 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 20.27 Mn
10 Arvinas 609.77 Mn 41.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 67,500.00
Sep 30, 2021 8,125.00
Jun 30, 2021 8,125.00
Mar 31, 2021 16,250.00
Dec 31, 2020 51,250.00
Sep 30, 2020 16,250.00
Jun 30, 2020 16,250.00
Mar 31, 2020 16,250.00
Dec 31, 2019 16,250.00
Sep 30, 2019 22,903.00
Jun 30, 2019 22,778.00
Mar 31, 2019 23,638.00
Dec 31, 2018 24,636.00
Sep 30, 2018 12,264.00
Jun 30, 2018 9,871.00
Mar 31, 2018 10,669.00
Dec 31, 2017 11,451.00
Sep 30, 2017 12,219.00
Jun 30, 2017 12,973.00
Mar 31, 2017 13,713.00